Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form
CA 2408956 C · Owner: Sherwood, Jill K. · Inventors: Gaylo, Christopher M.; Cima, Michael J.; Yoo, Jaedeok
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A drug delivery device such as an oral dosage form (ODF) with a toxic or potent core encapsulated by a non-toxic region. The non-toxic region may be a region including multiple layers, coatings shells, and combinations thereof, which provides protection to and isolation from the toxic or potent core. The drug in the toxic or potent core is incorporated into the dosage form via for , example, three-dimensional printing as a solution, solubilization or , suspension of solid particles in liquid rather than by the more conventional , handling and compressing of dry powder. This minimizes the likelihood of creating airborne particles of the toxic drug during manufacturing hence , controlling …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 18, 2001 and granted July 12, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 18, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 18, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.